Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02XQE
|
|||
Drug Name |
PMID29473428-Compound-39
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
MERCK PATENT GMBH SHERER, Brian A
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H20F2N2
|
|||
Canonical SMILES |
C1CCC(CC1)C(CC2C3=C(C=CC=C3F)C4=CN=CN24)F
|
|||
InChI |
1S/C18H20F2N2/c19-14-8-4-7-13-17-10-21-11-22(17)16(18(13)14)9-15(20)12-5-2-1-3-6-12/h4,7-8,10-12,15-16H,1-3,5-6,9H2
|
|||
InChIKey |
OHWIXLJBJCDWBA-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Indoleamine 2,3-dioxygenase 1 (IDO1) | Target Info | Antagonist | [1] |
Target's Patent Info | Indoleamine 2,3-dioxygenase 1 (IDO1) | Target's Patent Info | [1] | |
BioCyc | Superpathway of tryptophan utilization | |||
Tryptophan degradation | ||||
L-kynurenine degradation | ||||
Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde | ||||
NAD de novo biosynthesis | ||||
KEGG Pathway | Tryptophan metabolism | |||
Metabolic pathways | ||||
African trypanosomiasis | ||||
NetPath Pathway | TSLP Signaling Pathway | |||
IL5 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | ||||
Pathwhiz Pathway | Tryptophan Metabolism | |||
Reactome | Tryptophan catabolism | |||
WikiPathways | Tryptophan metabolism | |||
Metabolism of amino acids and derivatives |
References | Top | |||
---|---|---|---|---|
REF 1 | A patent review of IDO1 inhibitors for cancer.Expert Opin Ther Pat. 2018 Apr;28(4):317-330. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.